Microdosing is a tolerability-first approach to reach your goals on smaller dosages
Food and Drug Administration (FDA), which approves medicines for safety and use, approved Wegovy in 2021 for use in adults with obesity (body mass index, BMI, of 30 kg/m or higher) or overweight (BMI of 27 kg/m or higher) plus at least one weight related health problem such as high blood pressure, high cholesterol, or type 2 diabetes 7 , 8
Outside References Sikiric P, et al
Both assays were performed according to the manufacturers protocols, with slight modifications for dilutions of the sample
Black patients are less likely to receive recommendations for these drugs, even when they meet clinical criteria
Tsai YT, Cheng PC, Pan TM (2010) Immunomodulating activity of Lactobacillus paracasei subsp